Zomedica (NYSE American: ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, provided a business update. Revenue for the fourth quarter of 2023 is expected to be over $7 million, a new record for the Company, compared to record fourth quarter 2022 revenue of $6.2 million, primarily driven by strong performance across many product lines, highlighted by a record quarter in the Therapeutic Device segment. "The fourth quarter capped off a record year for Zomedica. We grew full year revenue by over 32%, due in large part to the continued strength in our Therapeutic Devices segment, further bolstered by early adoption of newly launched products in our Diagnostics segment throughout the year," commented Zomedica Chief Executive Officer, Larry Heaton.

Sharps Technology (Nasdaq: STSS), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, and Roncadelle Operations, a driving force in the development of novel medical drug delivery devices with its seasoned team boasting over two decades of healthcare expertise, signed a Letter of Intent (LOI) to enter into a sales and marketing agreement which would enable the Company and Roncadelle to cooperatively sell and distribute each other’s products to their respective areas of influence and expand Sharps’ American-based product market into Europe, the Middle East, Africa, and the Asia-Pacific region. The LOI was inked on January 16 and will be celebrated at the upcoming Pharmapack 2024 event in Paris later in the month. The LOI is subject to the negotiation of definitive documentation between the parties. Accordingly, there can be no assurance that the parties will enter into a definitive agreement.

American Resources’ (Nasdaq: AREC) wholly owned subsidiary, ReElement Technologies LLC ("ReElement"), a leading provider of high performance refining capacity of rare earth and critical battery elements, today announced it has engaged law firm Alexander & Partner Rechtsanwälte mbB for the formation of ReElement Technologies Ghana LLC ("ReElement Ghana") under Ghanaian law along with future work in other key ex-US markets under development by ReElement Technologies.

1606 Corp. (OTC: CBDW), an industry leader in the development of AI-powered merchandising chatbots, announced a groundbreaking Independent Sales Organization (ISO) agreement with CannaSiteCo, a dynamic player in the cannabis digital space. This strategic partnership aims to leverage CannaSite's robust client base and industry influence to expand the reach and impact of 1606 Corp.'s innovative chatbot solutions.